Life sciences investor KdT Ventures raises $100M fund to back new startups

Kyle LaHucik

Senior Reporter

Life sciences VC shop KdT Ventures disclosed its $100 million fourth fund on Wednesday morning, just over two years after announcing an $80 million fund …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Life sciences investor KdT Ventures raises $100M fund to back new startups

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Life sci­ences in­vestor KdT Ven­tures rais­es $100M fund to back new star­tups

Senior Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Life sciences investor KdT Ventures raises $100M fund to back new startups